Browse by Author Yuen, J

TitleAuthor(s)YearView Count
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinomaYau, T; Cheng, PN; Chan, P; Chan, W; Chen, L; Yuen, J; Pang, R; Fan, ST; Poon, RT201295
Overcoming obstacles associated with other learning experiences and school-based assessment: Perspectives of high school students with visual impairment in Hong Kong - Collaborative research project reportYuen, MT; Ho, J; Chung, YB; Fong, RW; Cheng, S; Ho, JH; Kwok, D; Ho, S; Tsui, J; Chiu, CW; Cheng, CKY; Yuen, J; Cheung, V201287
A comprehensive HBV array for the detection of HBV mutants and genotypeChan, K; Yam, I; Yuen, J; Yuen, MF; Lai, CL; Alexander, GJ; Chan, TK; Chan, V2011185
Knowledge building international project: Designs for deep understandingLaferrière, T; Perreault, C; Boutin, PA; Law, N; Yuen, J; Montané, M; Lopez, OH; Boluda, P; Blancafort, M201131
Automated data analysis to support teacher's knowledge building practiceJing, L; Yuen, J; Wong, W; Law, N; Zhang, Y; Allaire, S; Perreault, C; Laferrière, T; Teplovs, C201137
Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatmentFung, J; Lai, CL; Young, J; Wong, DKH; Yuen, J; Seto, WK; Yuen, MF2011248
Stability of hepatitis B surface antigen over time: Implications for studies using stored seraFung, J; Lai, CL; Young, J; Wong, DKH; Yuen, J; Seto, WK; Yuen, MF2011150
Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: Implications for antiviral therapyFung, J; Seto, WK; Lai, CL; Yuen, J; Wong, DKH; Yuen, MF2011277
Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: Outcome at 2 YearsFung, J; Lai, CL; Yuen, J; Cheng, C; Wu, R; KaHo Wong, D; Seto, WK; Hung, IFN; Yuen, MF2011541
Natural history of chronic hepatitis C: Genotype 1 versus genotype 6Seto, WK; Lai, CL; Fung, J; Hung, I; Yuen, J; Young, J; Wong, DKH; Yuen, MF20103,020
Multivocality in visualization and interaction analysis: An exploration of the role of argumentation and questioning in knowledge buildingLaw, NWY; Lund, K; Yuen, J; Leng, J; Lu, J200994
The duration of lamivudine therapy for chronic hepatitis b: Cessation vs. continuation of treatment after HBeAg seroconversionFung, J; Lai, CL; Tanaka, Y; Mizokami, M; Yuen, J; Wong, DKH; Yuen, MF200951
Risk Factors and Prognostic Factors of Local Recurrence after Radiofrequency Ablation of Hepatocellular CarcinomaLam, VWT; Ng, KKC; Chok, KSH; Cheung, TT; Yuen, J; Tung, H; Tso, WK; Fan, ST; Poon, RTP2008184
Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinomaNg, KK; Poon, RT; Lo, CM; Yuen, J; Tso, WK; Fan, ST2008106
Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: Analysis of risk factors and prognostic factorsLam, VWT; Ng, KK; Chok, KSH; Cheung, TT; Yuen, J; Tung, H; Tso, WK; Fan, ST; Poon, RTP2008114
High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: Importance of tumor biomarker in ablative therapiesPoon, RTP; Lau, C; Pang, R; Ng, KK; Yuen, J; Fan, ST2007162
Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinomaKhan, MR; Poon, RTP; Ng, KK; Chan, AC; Yuen, J; Tung, H; Tsang, J; Sheung, TF2007135
Duodenopleural fistula formation after percutaneous radiofrequency ablation for recurrent hepatocellular carcinomaChan, FS; Ng, KK; Poon, RT; Yuen, J; Tso, WK; Fan, ST200744
A learnable content & participation analysis toolkit for assessing CSCL learning outcomes and processesLaw, N; Yuen, J; Huang, R; Li, Y; Pan, N200733
Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusionNg, KK; Poon, RT; Lam, CM; Yuen, J; Tso, WK; Fan, ST2006106